Abstract
[Extract] In their Article (May 2, p 1729) on oseltamivir treatment for influenza, Joanna Dobson and colleagues reported both fewer admittances to hospital for those treated with oseltamivir in the subgroup of patients classified as infected and fewer lower respiratory tract complications in patients treated with antibiotics as a surrogate for severity than in placebo recipients. However, our Cochrane review found insufficient evidence of a difference between groups for complications classified as serious or leading to patient withdrawal, or for rate of admittance to hospital.
| Original language | English |
|---|---|
| Pages (from-to) | 1133-1134 |
| Number of pages | 2 |
| Journal | The Lancet |
| Volume | 386 |
| Issue number | 9999 |
| DOIs | |
| Publication status | Published - 19 Sep 2015 |
Fingerprint Dive into the research topics of 'Oseltamivir for influenza'. Together they form a unique fingerprint.
Cite this
Jones, M., Hama, R., & Del Mar, C. (2015). Oseltamivir for influenza. The Lancet, 386(9999), 1133-1134. https://doi.org/10.1016/S0140-6736(15)00200-7